Test Price
2,800 AED✅ Home Collection Available
BRWD3 Gene X‑Linked Intellectual Disability Type 93 Genetic Test in the UAE | 2,800 AED | ISO Accredited
Executive Summary & Core Metrics
This NGS‑based single‑gene analysis detects pathogenic variants in the BRWD3 gene, causing X‑linked intellectual disability type 93. The test covers all coding exons and splice junctions with >99.9% diagnostic sensitivity, enabling accurate diagnosis, carrier detection, and family planning.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic post‑test clinical guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The BRWD3 NGS test uses next‑generation sequencing to comprehensively analyse the BRWD3 gene on the X chromosome. All coding exons and conserved splice junctions are sequenced, with bioinformatic verification to detect missense, nonsense, splice‑site, and small indel mutations. Results are interpreted in the context of clinical history and family pedigree.
| Feature | Our BRWD3 NGS Test | Standard Sanger Sequencing |
|---|---|---|
| Precision | >99.9% sensitivity for all coding mutations | Limited to known hotspot mutations |
| Methodology | NGS with bioinformatics verification | Sanger exon‑by‑exon, full gene |
| Turnaround Time | 3–4 weeks | 6–8 weeks for complete coverage |
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I emphasize that this BRWD3 NGS test provides critical molecular evidence for X‑linked intellectual disability type 93. However, results must always be integrated with a comprehensive clinical examination, developmental assessment, and thorough family history. Genetic counselling before and after testing is essential for informed decision‑making.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Advisory – Medication & Clinical Guidance
⚠ Do not discontinue prescribed medication without consulting your doctor.
This test is not a diagnostic substitute. Pre‑test and post‑test genetic counselling is mandatory under Federal Decree‑Law No. 4 of 2016 on Medical Liability. Always correlate test results with clinical findings.
Exclusion Criteria & ER Red Flags
- Exclusion: Patients who decline genetic counselling, minors under 18 without parental/guardian consent (per Federal Decree‑Law No. 4 of 2016), acute medical emergencies, and individuals who received a blood transfusion within the last 2 weeks (may compromise DNA extraction).
- ER Red Flags: Seek immediate medical attention if the patient experiences sudden loss of consciousness, uncontrolled seizures, acute behavioral changes, or signs of severe metabolic crisis.
Patient FAQ & Clinical Guidance
1. What does the BRWD3 gene test detect?
Our BRWD3 NGS test detects pathogenic gene variants causing X‑linked intellectual disability type 93. This single‑gene analysis covers the entire coding region of the BRWD3 gene, identifying missense, nonsense, splice‑site mutations, and small insertions/deletions. It is the gold standard for confirming the diagnosis in symptomatic males and carrier detection in female relatives.
2. How long does it take to get BRWD3 results?
You get your complete BRWD3 genetic report within 3 to 4 weeks via a secure patient portal. After sample collection, our ISO‑certified laboratory processes the DNA using NGS, followed by rigorous bioinformatic analysis and clinical interpretation. Expedited courier and VIP phlebotomy ensure sample integrity.
3. Is the test covered by insurance?
Direct billing verification can be requested via WhatsApp at +971 54 548 8731. Coverage depends on your insurance plan; we assist with pre‑authorization documentation.
UAE Regulatory & Data Privacy Adherence
This testing service strictly adheres to UAE federal regulations:
- Data Protection: Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) ensures the confidentiality and security of your genetic data.
- Health Data: Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields governs the secure handling and transmission of medical information.
- Patient Safety & Consent: Federal Decree‑Law No. 4 of 2016 on Medical Liability mandates informed consent and ethical conduct in all clinical procedures.
- Quality Management: ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) for quality management in laboratory services.
Clinical & Logistical Metadata
| Test Name | BRWD3 Gene X‑Linked Intellectual Disability Type 93 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (peripheral) – VIP Mobile Phlebotomy & Temperature‑Controlled Home Collection available daily 8 AM – 11 PM. |
| Methodology Used | Next‑Generation Sequencing (NGS) covering all coding exons and splice junctions |
| ICD-10-CM Code | F78.9 (Intellectual disability, unspecified) |
| LOINC Code | 101357-0 (BRWD3 gene mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians